Yves Marie P.
- Country
- France
- Department
- Rheumatology
Research Overview
- Efficacy and Safety of Topical Clobetasol Propionate versus Placebo in Adult Patients with Inflammatory Hand Osteoarthritis: A Randomized Controlled Trial
- Open-Label Evaluation of VRDN-001 in Non-Responders with Thyroid Eye Disease from VRDN-001-101 and VRDN-001-301 Studies
- Efficacy and Safety Evaluation of Rosnilimab in Moderate to Severe Rheumatoid Arthritis: A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study
Data & Insights
Has run more than one trial at 11 of 91 partner sites.
Specializations
Rheumatoid Arthritis Research
The investigator specializes in therapeutic approaches for rheumatoid arthritis, with particular focus on biodrug treatment optimization and evaluation of novel therapeutic agents. Their work encompasses studies of adalimumab treatment strategies and investigation of emerging medications like rosnilimab for moderate to severe cases.
- Biodrug tapering strategies
- Treatment optimization for moderate to severe cases
- Novel therapeutic evaluation
Thyroid Eye Disease Studies
The investigator conducts research in thyroid eye disease (TED) treatment, focusing on innovative therapeutic approaches using monoclonal antibodies. Their work includes evaluation of IGF-1 receptor targeted therapies and assessment of treatment responses in TED patients.
- Monoclonal antibody therapeutics
- Treatment efficacy assessment
- Long-term patient outcomes
Osteoarthritis Management
The investigator explores innovative treatments for base-of-thumb osteoarthritis, including the application of ultrasound-guided intra-articular injections. Their research involves evaluation of onabotulinumtoxinA combined with custom splinting techniques for pain management.
- Innovative injection techniques
- Pain management strategies
- Combined therapeutic approaches
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.